 So the project that I propose for my Marie Curie Fellowship is focused on research about a new technology for ablation of cardiac arrhythmias that is called pulse fill ablation and is based in reversible extroperation. The main advantage of this technique with respect to the classical ablation technique that is radiofrequency is that it's basically non-thermal. This fact makes that this technology is much safer than the current technologies. With the data that we have at this moment it seems that the technology has similar efficiency with respect to the classical radiofrequency ablations but with much safer profile. I work with in vitro cells that allows me to do the basic stuff where I really understand what are the optimal parameters to perform reversible extroperation. I'm working with the computer, working with computational models that what we do with these computational models is try to understand how the lesion that we create in a tissue will be and how to improve the safety profile of this lesion and avoid thermal effects. But at the end we also have to try and validate our studies in real models in living tissues. And here in Barcelona I had previously worked with a really good group in electrophysiology that is at the Sampout Hospital here in Barcelona. In fact I'm planning to perform a second one in this project of four months where I will be in the hospital working with cardiologists attending also to treatments of real patients, human patients, just as an observer to see how real treatments are performed. That also will help me to understand how to improve this technology and also to perform the final preclinical validation of this technology. I also will be working with this group of cardiologists. One of the activities that I proposed in my project is the organizing an international school of one day to explain the basis of the pulse filablation technology, the current state of development and also the future of this technology.